The DOI matches its Crossref record.
Interactions Between Estrogens and Catechol Amines III. Studies on the Methylation of Catechol Estrogens, Catechol Amines and other Catechols by the Catechol-O-Methyltransferase1 of Human Liver
Abstract
The substrate specificity of the catechol-O-methyltransferase, purified from human liver 380-fold, has been tested with a variety of compounds. Catechol estrogens, as well as catechol amines are methylated to their corresponding monomethyl ethers. The relation of the rates of methylation of catechol estrogens and catechol amines depended on enzyme and substrate concentration; under standard assay conditions, 2-hydroxy-17β-estradiol was the preferred substrate for the enzyme, as compared with epinephrine and other catechols tested. Km-values for 2-hydroxy-17β-estradiol were 15 μm, for 2-hydroxy-estrone 20 μm, for 2-hydroxy-estriol 25 μm and for-hydroxy-estrone 20 μm. For epinephrine and norepinephrine, Km-values of 300 μm and 200 μm, respectively, were obtained. The ratio of formation of the isomeric monomethyl ethers of catechol estrogens varied between 1.3 and 95, depending on the substrate incubated. On the basis of kinetic studies with different enzyme preparations, different inhibitors and different concentrations of the substrates, it is concluded that both catechol estrogens and catechol amines are methylated by the same Catechol-O-methyltransferase. The enzymic methylation of epinephrine was inhibited competitively by 2- and 4-hydroxylated estrogens; the Ki-values were 7.0 μm for 2-hydroxy-17β-estradiol, 8.5 μm for 2-hydroxy-estrone, 12.2 μm for 2-hydroxy-estriol, 50 μm for 4-hydroxy-estrone and, for comparison, 154 μm for the addition of norepinephrine. A non-competitive inhibition was observed with the corresponding isomeric monomethyl ethers. The extent of inhibition not only depended on the relative concentrations of substrates and inhibitors, but also on the concentrations of MgCl2S-adenosylmethionine and enzyme. The results reported here indicate that the enzymic methylation and biological inactivation of neurotransmitters is strongly inhibited by 2-hydroxy-estrogens. These findings are of possible clinical relevance with respect to the regulation of blood pressure under normal and pathological conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“COMT methylates 2- and 4-hydroxyestrogens, thereby producing the so-called methoxyestrogens [180].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [180]
Citations
Cited by
Sorted by citations
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Weinshilboum, R. M., Otterness, D. M., & Szumlanski, C. L. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.19 · Cited by 550
The Brain as a Target for Steroid Hormone Action
McEwen, B. S., Davis, P. G., Parsons, B., & Pfaff, D. W. (1979) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.02.030179.000433 · Cited by 512
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P. F., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
Crystal structure of catechol O-methyltransferase
Vidgren, J., Svensson, L., & Liljas, A. (1994) · Nature · doi:10.1038/368354a0 · Cited by 403
Estrogen Therapy for Severe Persistent Depressions in Women
Klaiber, E. L. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050060006 · Cited by 352
TENHUNEN, J., SALMINEN, M., LUNDSTRÖM, K., KIVILUOTO, T., SAVOLAINEN, R., & ULMANEN, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19083.x · Cited by 331
Dawling, S., Roodi, N., Mernaugh, R. L., Wang, X., & Parl, F. F. (2001) · PubMed · Cited by 250
Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells.
Schneider, J., Man-Ha, H. U. H., Bradlow, H. L., & Fishman, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42922-x · Cited by 247
Saab, P. G., Matthews, K. A., Stoney, C. M., & McDonald, R. H. (1989) · Psychophysiology · doi:10.1111/j.1469-8986.1989.tb01917.x · Cited by 237
Zhu, B. T., Ezell, E. L., & Liehr, J. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42348-9 · Cited by 237
Owens, J. F., Stoney, C. M., & Matthews, K. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2794 · Cited by 202
Cyclical variation in paroxysmal supraventricular tachycardia in women
Rosano, G. M. C., Leonardo, F., Rosano, G. M. C., De Luca, F., Sarrel, P. M., Beale, C. M., & Collins, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90867-3 · Cited by 189
Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA
LUNDSTR, K., Salminen, M., Jalanko, A., Savolainen, R., & Ulmanen, I. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.181 · Cited by 169
Role of female gonadal hormones in the CNS: Clinical and experimental aspects
Maggi, A. C., & Pérez, J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90525-9 · Cited by 165
Ritter, J. K., Sheen, Y. Y., & Owens, I. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39016-7 · Cited by 155
Scanlon, P. D., Raymond, F. A., & Weinshilboum, R. M. (1979) · Science · doi:10.1126/science.758679 · Cited by 153
Martucci, C. P., & Fishman, J. (1979) · Endocrinology · doi:10.1210/endo-105-6-1288 · Cited by 149
Catechol Estrogen-Forming Enzyme of Brain: Demonstration of a Cytochrome P450 Monooxygenase
Paul, S. M., Axelrod, J., & Diliberto, E. J. (1977) · Endocrinology · doi:10.1210/endo-101-5-1604 · Cited by 148
MacLusky, N. J., Naftolin, F. N., Krey, L. C., & Franks, S. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90265-x · Cited by 135
Imipramine in adolescent major depression: plasma level and clinical response
Ryan, N. D., Puig-Antich, J., Cooper, T. B., RABINOVICH, H., Ambrosini, P. J., Davies, M., King, J., TORRES, D., & Fried, J. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb02686.x · Cited by 130
Metabolism of estrogens—natural and synthetic
Bolt, H. M. (1979) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(79)90018-4 · Cited by 128
Molecular cloning and characterization of rat liver catechol-O-methyltransferase
Salminen, M., Lundstrom, K. H., Tilgmann, C., Savolainen, R., Kalkkinen, N., & Ulmanen, I. (1990) · Gene · doi:10.1016/0378-1119(90)90231-f · Cited by 118
Rosano, G. M. C., Patrizi, R., Leonardo, F., Ponikowski, P. P., Collins, P. D., Sarrel, P. M., & Chierchia, S. L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00528-6 · Cited by 114
Martucci, C. P., & Fishman, J. (1976) · Steroids · doi:10.1016/0039-128x(76)90054-4 · Cited by 113
Changes in cognitive task performance across the menstrual cycle.
Broverman, D. M., Vogel, W., Klaiber, E. L., Majcher, D., Shea, D., & Paul, V. J. (1981) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077796 · Cited by 109
Merriam, G. R., MacLusky, N. J., Picard, M. K., & Naftolin, F. N. (1980) · Steroids · doi:10.1016/0039-128x(80)90062-8 · Cited by 111
Wallach, E. E., Fritz, M. A., & Speroff, L. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46628-8 · Cited by 99
2-Hydroxyestrone induced rise in serum luteinizing hormone in the immature male rat
Naftolin, F. N., Morishita, H., DAVIES, I. J., et al. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(75)90133-3 · Cited by 100
New, Selective Catechol-O-Methyltransferase Inhibitors as Therapeutic Agents in Parkinson’s Disease
Bonifati, V., & Meco, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00032-1 · Cited by 97
Estradiol and neurodegenerative oxidative stress
Nilsen, J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.12.005 · Cited by 98
2-Hydroxyestradiol interaction with dopamine receptor binding in rat anterior pituitary.
Schaeffer, J. M., & Hsueh, A. J. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50455-5 · Cited by 93
Roles of the gonadal steroid hormones in psychiatric depression in men and women
Vogel, W., Klaiber, E. L., & Broverman, D. M. (1978) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(78)90107-8 · Cited by 89
Physical Exercise and Menstrual Cycle Alterations
KEIZER, H. A., & Rogol, A. D. (1990) · Sports Medicine · doi:10.2165/00007256-199010040-00002 · Cited by 87
Gender differences in glucoregulatory responses to intense exercise
Marliss, E. B., Kreisman, S. H., Manzon, A., Halter, J. B., Vranić, M., & Nessim, S. J. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.2.457 · Cited by 89
The Role of Estrogen in Migraine: A Review and Hypothesis
Welch, K. M. A., Darnley, D., & Simkins, R. (1984) · Cephalalgia · doi:10.1046/j.1468-2982.1984.0404227.x · Cited by 86
“Catechol-o-methyltransferase is strongly inhibited by 2-hydroxylated, catechol estrogens (71-73), and estrogen inhibits MAO as well (74, 75).”
BackgroundForeman, M. M., & Porter, J. C. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb09957.x · Cited by 86
The application of positron emission tomography to the study of the normal menstrual cycle
Reiman, E. M., Armstrong, S. M., Matt, K. S., & Mattox, J. H. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019214 · Cited by 78
“…and their active metabolites on specific intracellular receptors, their modulatory effects on other endocrine and neurotransmitter systems (Ball et al, 1972; Wong et al, 1987; Clarke and Mazyani, 1990; Weiland and Wise, 1990, Toran-Allerand et al, 1992) or their effects on other processes.”
BackgroundVandewalle, B., & Lefèbvre, J. L. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90135-4 · Cited by 79
Perimenopausal Mental Disorders: Epidemiology and Phenomenology
Rasgon, N., Shelton, S., & Halbreich, U. M. (2005) · CNS Spectrums · doi:10.1017/s1092852900023166 · Cited by 76
Catecholestrogens are MCF-7 cell estrogen receptor agonists
Schütze, N., Vollmer, G., Tiemann, I., Geiger, M., & Knüppen, R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90319-r · Cited by 76
Self-citationKlaiber, E. L., Broverman, D. M., Vogel, W., Peterson, L. G., & Snyder, M. B. (1996) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00023-6 · Cited by 75
The biliary and urinary metabolites of [3H]17α-ethynylestradiol in women
Maggs, J. L., Grimmer, S. F. M., Orme, M. L., et al. (1983) · Xenobiotica · doi:10.3109/00498258309052280 · Cited by 76
Tenhunen, J., Salminen, M., Jalanko, A., UKKONEN, S., & Ulmanen, I. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.253 · Cited by 74
A new method for preventing oxidative decomposition of catechol estrogens during chromatography
Gelbke, H. P., & Knüppen, R. (1972) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)91900-4 · Cited by 75
Self-citationEstrogen‐Androgen Levels in Aging Men and Women: Therapeutic Considerations*
Greenblatt, R. B., Oettinger, M., & Cs, B. (1976) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1976.tb04294.x · Cited by 72
Russell, J. B., Mitchell, D. E., Musey, P. I., & Collins, D. C. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48192-6 · Cited by 70
Serum estrogen levels in men with acute myocardial infarction
Klaiber, E. L., Broverman, D. M., Haffajee, C. I., Hochman, J. S., Sacks, G. M., & Dalen, J. E. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90779-3 · Cited by 69
Serum estradiol levels in male cigarette smokers
Klaiber, E. L., Broverman, D. M., & Dalen, J. E. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90524-2 · Cited by 66
Association of COMT Val108/158Met genotype with smoking cessation
Munafò, M. R., Johnstone, E. C., Guo, B., Murphy, M. F. G., & Aveyard, P. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f44daa · Cited by 68
Sex, hormones and neuroeffector mechanisms
Hart, E. C., Charkoudian, N., & Miller, V. M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02192.x · Cited by 68
“The catecholoestrogens, 2- and 4-hydroxylestradiol, are formed by hydroxylation of estradiol by several enzymes, the most prominent being a cytochrome P-450-dependant monooxygenase (Ball et al. 1972a, Paul et al. 1977).”
BackgroundInteraction between oestrogens and neurotransmitters at the hypophysial-hypothalamic level
BREUER, H., & Köster, G. (1974) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(74)90092-2 · Cited by 67
Self-citationA simple chemical method for the synthesis of catechol estrogens
Gelbke, H. P., Haupt, O., & Knüppen, R. (1973) · Steroids · doi:10.1016/s0039-128x(73)80005-4 · Cited by 67
Self-citationJohnstone, E. C., Elliot, K. M., David, S. P., Murphy, M. F. G., Walton, R. T., & Munafò, M. R. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0936 · Cited by 66
“COMT is involved in the breakdown of catechol estrogens to estrone (28).”
BackgroundReduction of menopausal hot flushes by methyldopa
Nesheim, B. I., & S�tre, T. (1981) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542092 · Cited by 64
Erythrocyte catechol‐O‐methyltransferase activity in a Swedish population
Flodérus, Y., Ross, S. B., & Wetterberg, L. (1981) · Clinical Genetics · doi:10.1111/j.1399-0004.1981.tb00731.x · Cited by 61
Formation, metabolism and physiologic importance of catecholestrogens
Ball, P., & Knüppen, R. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90558-o · Cited by 61
Self-citationInfluence of Sex and Obesity on Plasma Catecholamine Response to Isometric Exercise*
Gustafson, A. B., & Kalkhoff, R. K. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-4-703 · Cited by 60
Depressive Symptoms in the Perimenopause: Prevalence, Assessment, and Guidelines for Treatment
Burt, V. K., Altshuler, L. L., & Rasgon, N. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809000320 · Cited by 60
Mondschein, J. S., Hersey, R. M., Dey, S. K., et al. (1985) · Endocrinology · doi:10.1210/endo-117-6-2339 · Cited by 59
Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones
Haglund, L., Köhler, C., Haaparanta, T., et al. (1984) · Nature · doi:10.1038/307259a0 · Cited by 59
Binding of 2-hydroxyestradiol to rat anterior pituitary cell membranes.
Schaeffer, J. M., Stevens, S. A., Smith, R. G., et al. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43468-0 · Cited by 59
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause
Miller, V. M., Garovic, V. D., Kantarci, K., Barnes, J. N., Jayachandran, M., Mielke, M. M., Joyner, M. J., Shuster, L. T., & Rocca, W. A. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-6 · Cited by 57
“These mechanisms include the synthesis and degradation of norepinephrine [16,17], the expression of adrenergic receptors on vascular smooth muscle [18-22], the regulation of ion fluxes in cardiac and vascular smooth muscle [23-30], the production of endothelium-derived vasoactive factors [31,32] which affect total per…”
BackgroundZhang, L., Jin, Y., Huang, M. T., & Penning, T. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00193 · Cited by 68
“COMT is a classical phase II enzyme and catalyzes the transfer of a methyl group from S-adenosyl-l-methionine (SAM) to the hydroxyl group of a variety of catechols including catecholamine neurotransmitters and the catechol estrogens (Axelrod and Tomchick, 1958; Axelrod, 1966; Ball et al., 1972).”
BackgroundThe pharmacokinetics of ethynyl estrogens. A review
Helton, E. D., & Goldzieher, J. W. (1977) · Contraception · doi:10.1016/0010-7824(77)90112-3 · Cited by 56
Goodman, J. E., Jensen, L. T., He, P., & Yager, J. D. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00003 · Cited by 55
Sexual Dimorphism in the Response of the GABAergic System to Estrogen Administration
Pérez, J., Zucchi, I., & Maggi, A. C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13091.x · Cited by 55
Enzymatic modulation of hormonal action at the target tissue
Gurpide, E. (1978) · Journal of Toxicology and Environmental Health · doi:10.1080/15287397809529660 · Cited by 54
Jellinck, P. H., Krey, L. C., Davis, P. G., Kamel, F., Luine, V. N., Parsons, B., Roy, E. J., & McEwen, B. S. (1981) · Endocrinology · doi:10.1210/endo-108-5-1848 · Cited by 53
Gupta, A., Kumar, P. H., Dineshkumar, T. K., Varshney, U., & Subramanya, H. S. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4935 · Cited by 52
Huh, M. M.-O., & Friedhoff, A. J. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37918-8 · Cited by 52
4-Hydroxyestrone: A new metabolite of estradiol-17β from humans
Williams, J. G., Longcope, C., & Williams, K. I. H. (1974) · Steroids · doi:10.1016/0039-128x(74)90021-x · Cited by 52
Effect of 2-hydroxyestradiol on binge intake in rats
Babbs, R. K., Wojnicki, F. H. E., & Corwin, R. L. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.03.029 · Cited by 49
Acute electrophysiologic effect of estradiol 17β in menopausal women
Rosano, G. M. C., Leonardo, F., DICANDIA, C. D., Sheiban, I., Pagnotta, P. A., Pappone, C., & Chierchia, S. L. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01251-0 · Cited by 50
Estrogen replacement therapy and nocturnal periodic limb movements: A randomized controlled trial
Polo‐Kantola, P. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01191-1 · Cited by 49
Acute administration of high doses of estrogen increases glucose utilization throughout brain
Namba, H., & Sokoloff, L. (1984) · Brain Research · doi:10.1016/0006-8993(84)91276-9 · Cited by 49
Estrogen Replacement Therapy for the Prevention and Treatment of Alzheimer??s Disease
Henderson, V. W. (1997) · CNS Drugs · doi:10.2165/00023210-199708050-00001 · Cited by 49
Purification of urine for quantification of the complete estrogen profile
Fotsis, T., Järvenpää, P., & Adlercreutz, H. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90314-3 · Cited by 48
Zhu, B. T., Roy, D., & Liehr, J. G. (1993) · Endocrinology · doi:10.1210/endo.132.2.8381068 · Cited by 47
Gender Differences in Hypertension and Kidney Disease
Reyes, D., Lew, S. Q., & Kimmel, P. L. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.11.010 · Cited by 44
The excretion of five different 2-hydroxyoestrogen monomethyl ethers in human pregnancy urine
Gelbke, H. P., & Knüppen, R. (1976) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(76)90112-6 · Cited by 45
Self-citationSteroid Effects on the Secretory Modalities of Gonadotropin-Releasing Hormone Release*
Melrose, P. A., & GROSS, L. (1987) · Endocrinology · doi:10.1210/endo-121-1-190 · Cited by 44
Colzato, L. S., & Hommel, B. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00065 · Cited by 42
“After estrogen enters the brain, it is converted into cathecol estrogen, which has been considered to inhibit the catechol Omethyltransferase (Ball et al., 1972), an enzyme responsible for the degradation of DA in prefrontal cortex (PFC).”
BackgroundCardioprotective effects of ovarian hormones
Rosano, G. M. C., Chierchia, S. L., Leonardo, F., et al. (1996) · European Heart Journal · doi:10.1093/eurheartj/17.suppl_d.15 · Cited by 43
Thakker, D. R., Boehlert, C. C., Kirk, K. L., Antkowiak, R., & Creveling, C. R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42449-5 · Cited by 42
Cell‐free synthesis of rat and human catechol O‐methyltransferase
Ulmanen, I., & Lundstrom, K. H. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16464.x · Cited by 42
Lundstrom, K. H., Tilgmann, C., Peränen, J., Kalkkinen, N., & Ulmanen, I. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90479-j · Cited by 41
Dynamics of estradiol and testosterone and seminal fluid indexes in smokers and nonsmokers
Klaiber, E. L., & Broverman, D. M. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60196-6 · Cited by 41
Biochemistry and Pharmacology of Catechol-O-Methyltransferase Inhibitors
Nissinen, E., & Männistö, P. T. (2010) · International review of neurobiology · doi:10.1016/b978-0-12-381326-8.00005-3 · Cited by 40
Lewis, J. S., Thomas, T., Pestell, R. G., Albanese, C., Gallo, M. A., & Thomas, T. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01599 · Cited by 40
“16 -Hydroxylated metabolites stimulate breast cancer cell growth, whereas the 2-hydroxylated estrogens inhibit cell growth (Ball et al. 1972, Seegers et al. 1989, Lottering et al. 1992, Zhu & Conney 1998).”
VARIATION IN ACTIVITY OF MONOAMINE METABOLIZING ENZYMES IN RAT LIVER DURING PREGNANCY
Parvez, S., Parvez, S., & Youdim, M. B. H. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07355.x · Cited by 38
Catechol-O-methyltransferase in human breast cancers
Assicot, M., Contesso, G., & Bohuon, C. (1977) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(77)90173-6 · Cited by 38
Omidvar, M., Stolk, L., Uitterlinden, A. G., Albert Hofman, D., van Duijn, C. M., & Tiemeier, H. W. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328317f3f8 · Cited by 35
Ceresini, G., Freddi, M., Morganti, S., Rebecchi, I., Modena, A. B., Rinaldi, M., Manca, C., Amaducci, A., Rio, G. D., & Valenti, G. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00523-4 · Cited by 36
Sex differences in the adrenergic response to hypoglycemic stress in human
Claustre, J., Peyrin, L., Fitoussi, R., & Mornex, R. (1980) · Psychopharmacology · doi:10.1007/bf00431970 · Cited by 35
“Estrogens may, however, interact with catecholamine metabolism since they are able to inhibit competitively the enzyme catechol O-methyl transferase (COMT) (Ball et al., 1972), and catecholamine uptake 2 (Iversen, 1973).”
BackgroundSoluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland
Tenhunen, J., Heikkilä, P., Alanko, A., Heinonen, E., Akkila, J., & Ulmanen, I. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00197-4 · Cited by 35
Davidson, L., Rouse, I. L., Vandongen, R., et al. (1985) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1985.tb00899.x · Cited by 35
A radioimmunoassay method for urinary catechol estrogens
Chattoraj, S. C. (1978) · Steroids · doi:10.1016/0039-128x(78)90051-x · Cited by 34
Estrogen modulates inhibition of return in healthy human females
Colzato, L. S., Pratt, J., & Hommel, B. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.11.003 · Cited by 33
Metadata
- Authors
- BALL, P., KNUPPEN, R., HAUPT, M., & BREUER, H.
- Affiliations
- University of Bonn (DE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1972-04
- Volume
- 34
- Issue
- 4
- Pages
- 736-746
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2010928336
- Cited by
- 280
- References
- 0
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- catechol estrogens, epinephrine, norepinephrine, methylation, 2-hydroxyestrone, 4-hydroxyestrone, monomethyl ether, substrate specificity, enzyme kinetics, competitive inhibition, non-competitive inhibition, human liver
- MeSH terms
- Adult, Carbon Isotopes, Catecholamines, Catechols, Chemistry, Chlorides, Cysteine, Dopamine, Epinephrine, Estradiol, Estriol, Estrogens, Estrone, Humans, Kinetics, Liver, Magnesium, Male, Mandelic Acids, Methylation, Methyltransferases, Norepinephrine, S-Adenosylmethionine, Time Factors, Chemical Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review